Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
December 16th, 2021 |
HIV Prevention and Alcohol (R34 Clinical Trials Optional) |
National Institutes of Health |
October 6th, 2023 |
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) |
National Institutes of Health |
December 7th, 2021 |
Deciphering Immune-CNS interactions in people living with HIV on Anti-Retroviral therapy (R01 Clinical Trial Optional) |
National Institutes of Health |
February 22nd, 2022 |
Strengthening Public Health Laboratory Systems in the Republic of Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
May 2nd, 2022 |
Strengthening Syringe Services Programs |
Centers for Disease Control NCHHSTP |
June 20th, 2024 |
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) |
National Institutes of Health |
October 20th, 2021 |
Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2024 |
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) |
National Institutes of Health |
October 15th, 2021 |
Ethiopia Collaboration Learning Adapting (CLA) Platform |
Ethiopia USAID Addis Ababa |
December 7th, 2021 |
Deciphering Immune-CNS interactions in HIV utilizing in-vitro and in-vivo model systems (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
February 22nd, 2022 |
Provision of Voluntary Medical Male Circumcision (VMMC) for HIV Prevention in the Republic of South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
June 6th, 2022 |
Strengthening Collaboration Between Tb Control Programs And Affiliated Partners In The United States |
Centers for Disease Control NCHHSTP |
May 18th, 2022 |
Strengthening Civil Surgeons' Capacity to Improve LTBI Surveillance and Outcomes Among Status Adjusters |
Centers for Disease Control NCHHSTP |
November 8th, 2021 |
Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 20th, 2021 |
FY 2021 Regional Disaster Health Response System |
Assistant Secretary for Preparedness and Response |
September 7th, 2024 |
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) |
National Institutes of Health |
September 7th, 2024 |
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
October 29th, 2021 |
Limited Competition: Genome Sequencing Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
November 30th, 2021 |
Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 6th, 2023 |
Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
|
September 16th, 2021 |
Pepfarmedia Trainingand Hiv Anti-stigma Programs |
US Mission to Ghana |
January 14th, 2022 |
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) |
National Institutes of Health |
September 20th, 2021 |
Pepfar Media Training And Hiv Anti-stigma Programs |
US Mission to Ghana |
November 15th, 2023 |
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2024 |
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH)) |
National Institutes of Health |
August 27th, 2021 |
Emergency Department Substance Use Surveillance System |
Office of National Drug Control Policy |
November 10th, 2021 |
Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
March 3rd, 2022 |
High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 - Clinical Trial Not Allowed) |
National Institutes of Health |
February 28th, 2022 |
Kampala Regional Mechanism for Reaching and Sustaining Epidemic Control in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 28th, 2022 |
Improving Electronic Medical Records System Utilization and Data Use in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 25th, 2022 |
Sustaining HIV Epidemic Control through Efficient Case Finding and Quality Care and Treatment Services in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
November 10th, 2021 |
Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
November 10th, 2021 |
Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) |
National Institutes of Health |
December 9th, 2021 |
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) |
National Institutes of Health |
February 25th, 2022 |
Provision of Salary Support for Additional Health Care Workers to Support Ministry of Health to Sustain Epidemic Control in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
November 11th, 2021 |
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
February 13th, 2024 |
Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required) |
National Institutes of Health |
February 13th, 2024 |
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) |
National Institutes of Health |
September 10th, 2024 |
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 25th, 2022 |
Supporting the Mozambican Ministry of Health (MISAU) with Human Resources for Health to Achieve HIV Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |